Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Niying Li"'
Autor:
Mohammed Zuber, Sreelatha Akkala, Niying Li, Sajesh K. Veettil, Chia Jie Tan, Lorenzo Villa Zapata
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
ABSTRACT Background Bruton's tyrosine kinase inhibitors (BTKi) and the B‐cell lymphoma 2 (BCL2) inhibitor venetoclax have significantly improved outcomes and achieved durable remission in patients with chronic lymphocytic leukemia (CLL). BTKi/venet
Externí odkaz:
https://doaj.org/article/fd3b96b5f0bd492490ba6069b45ea198
Autor:
Niying Li, Kevin A. Look
Publikováno v:
INNOVATIONS in Pharmacy, Vol 13, Iss 1 (2022)
Background: Medication management tasks are commonly performed by family caregivers caring for patients with dementia, but caregivers also reported difficulties in performing these tasks. Objectives: Using the 2017 National Study of Caregiving (NSO
Externí odkaz:
https://doaj.org/article/0aff8b2ef73d4789bd8dc67de0903ac7
Publikováno v:
American Journal of Managed Care. Jun2024, Vol. 30 Issue 6, pe169-e171. 3p.
Autor:
Rupesh Panchal, Danielle Nguyen, Priyanka Ghule, Niying Li, Theodoros Giannouchos, Raymond J Pan, Joseph Biskupiak, Laura Britton, Robert Nohavec, Stacey Slager, Surachat Ngorsuraches, Diana Brixner
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:139-150
Publikováno v:
Li, N & Ercia, A 2020, ' The effects of private health insurance on universal health coverage objectives in china: A systematic literature review ', International Journal of Environmental Research and Public Health, vol. 17, no. 6, 2049 . https://doi.org/10.3390/ijerph17062049
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 17, Iss 6, p 2049 (2020)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 17, Iss 6, p 2049 (2020)
Background: We conducted a systematic review on the role of private health insurance to complement the social health insurance system towards achieving universal health coverage in China. This review presents the impacts of private health insurance o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103045674c29058d2ad4c55e5e6916ba
http://www.scopus.com/inward/record.url?eid=2-s2.0-85082254456&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85082254456&partnerID=MN8TOARS
Publikováno v:
Bulletin of the World Health Organization. Jun2017, Vol. 95 Issue 6, p430-436. 7p. 1 Diagram, 2 Charts.
Publikováno v:
WIDER Working Paper
Bulletin of the World Health Organization
Bulletin of the World Health Organization
To assess the characteristics and incidence of medical litigation in China and the potential usefulness of the records of such litigation as an indicator of health-care quality.We investigated 13 620 cases of medical malpractice litigation that ended
Publikováno v:
Journal of forensic and legal medicine. 67
Objectives This study aims to extend the current understanding of violence against health professionals and facilities in China, with data from an authoritative, national-representative, but under-researched data source – litigation records, and di
Publikováno v:
WIDER Working Paper ISBN: 9789292563707
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d66f178a33cc6e2d8a02c13a94c86d48
https://doi.org/10.35188/unu-wider/2017/370-7
https://doi.org/10.35188/unu-wider/2017/370-7
Publikováno v:
Journal of Drug Targeting. 21:257-264
Oridonin (ORI) is a bioactive diterpenoid compound extracted from the well known Chinese traditional medicine Rabdosia rubescens. The aim of this study was to prepare ORI loaded liposomes surface-modified with galactose (NOH-ORI-LP) and evaluate thei